@AndrewCrawford79 @Edin89 I think there needs to be a push in Congress to tax imported cannabis - this is not a problem since $CLVR's product is so inexpensive, and in fact would be popular, since politicians love to tax "sin".
@Edin89 The name of the game is to just not get into debt. I think $CLVR is at that point. And yes, the idea is that at some point, cannabis becomes legalized enough so that some big company - I'm guessing a tobacco company, but could be a pharma one - will see the value of having $CLVR's operation, and will just buy it outright.
This is when the payoff will happen.
$CLVR there is some movement and consolidation in the market… hopefully someone will acquire clvr too…
Otherwise I don’t believe we will see any profits near term with this one…
$CLVR While there is nothing specific to Clever Leaves, this discusses what a company needs to do to get a GMP. If you have a little time to kill, It's somewhat interesting. https://www.youtube.com/watch?v=LhPpnzX8jx0&t=932s
$CLVR “The medicinal cannabis market continues to expand strongly in Brazil. In 2025, the sector generated R$ 970.9 million and registered approximately 873,000 patients in treatment, a growth of about 30% compared to the previous year. The expectation is that this segment will reach an economic potential of R$ 9.5 billion in the coming years.” wrote Fala Você Notícias about Kaya Mind’s analysis. https://thetalmangroup.com/how-much-is-brazils-medical-cannabis-market-worth/
$CLVR everyone should watch the TDR from yesterday titled is the framework ready. Not the first half bs the second half. Really eye opening. Talks about the pathway. We are holding what I believe is the winning ticket!
https://www.youtube.com/live/bwn8tna1i8I?is=kbrdorQb1KhNh1lu
$CLVR please have a look at this. Shadd from the Dales report says it. The future is Pharma API’s. This lines up perfectly with Clever Leaves business model. Not trying to get anyone’s hopes up, but this is really good news for clever leaves.
https://youtu.be/nfnogLpG-gI?is=vErkzYXAQ3tagMHU
